Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ISRCTN12974924) titled 'The efficacy and safety of a high- concentration hybrid hyaluronic acid in patients with knee osteoarthritis: an open-label study' on Jan. 20.
Study Type: Interventional
Study Design:
Prospective single-center open-label clinical study (Efficacy, Safety, Treatment)
Primary Sponsor: IBSA Farmaceutici (Italy)
Condition:
Kellgren-Lawrence grade 2-3 knee Osteoarthrosis
Musculoskeletal Diseases
Intervention:
Single-dose (Population A) or repeated-dose (Population B) intra-articular injections of Sinovial(R) HL 90 (4.5%).
Population A: single injection of Sinovial(R) HL 90. The follow-up period lasted 6 months.
P...